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idirectional signaling of integrin 
 
 
 
IIb
 
 
 
3
 
 requires the 
 
 
 
3
 
cytoplasmic domain. To determine the sequence in
the 
 
 
 
3
 
 cytoplasmic domain that is critical to integrin
signaling, cell lines were established that coexpress the
platelet receptor for von Willebrand factor (vWF), glyco-
protein Ib-IX, integrin 
 
 
 
IIb
 
, and mutants of 
 
 
 
3
 
 with truncations
at sites COOH terminal to T
 
741
 
, Y
 
747
 
, F
 
754
 
, and Y
 
759
 
. Truncation
at Y
 
759
 
 did not affect integrin activation, as indicated by
vWF-induced ﬁbrinogen binding, but affected cell spread-
 
ing and stable adhesion. Thus, the COOH-terminal RGT
sequence of 
 
 
 
3
 
 is important for outside-in signaling but not
B
 
inside-out signaling. In contrast, truncation at F
 
754
 
, Y
 
747
 
, or T
 
741
 
completely abolished integrin activation. A point mutation
replacing Y
 
759
 
 with alanine also abolished integrin activation.
Thus, the T
 
755
 
NITY
 
759
 
 sequence of 
 
 
 
3
 
, containing an NXXY
motif, is critical to inside-out signaling, whereas the intact
COOH terminus is important for outside-in signaling. In
addition, we found that the calcium-dependent protease
calpain preferentially cleaves at Y
 
759
 
 in a population of 
 
 
 
3
 
during platelet aggregation and adhesion, suggesting that
calpain may selectively regulate integrin outside-in signaling.
 
Introduction
 
The prototype integrin, 
 
 
 
IIb
 
 
 
3
 
, plays critical roles in platelet
adhesion and aggregation. Normally, 
 
 
 
IIb
 
 
 
3
 
 on circulating
platelets is present in a “resting” form, with a low affinity for
its ligands such as soluble fibrinogen and von Willebrand
factor (vWF).* Upon vascular injury, exposure of platelets to
soluble agonists, such as thrombin and ADP, or extracellular
matrix adhesive proteins, such as collagen and vWF, induces
“inside-out” signals activating the ligand-binding function
of 
 
 
 
IIb
 
 
 
3
 
 (Ginsberg et al., 1992; Shattil et al., 1998; Parise,
1999). Ligand binding to 
 
 
 
IIb
 
 
 
3
 
 not only forms adhesive
bonds between platelets and adhesive ligands, but also transmits
“outside-in” signals to induce a series of cellular responses,
such as protein phosphorylation (Ferrell and Martin, 1989;
Golden et al., 1990; Lipfert et al., 1992; Clark et al., 1994;
Law et al., 1996; Lerea et al., 1999), elevation of intracellular
Ca
 
2
 
 
 
 (Pelletier et al., 1992), and cytoskeleton reorganization
(Phillips et al., 1980), leading to cell spreading, stabilization
of cell adhesion, and secondary wave of platelet aggregation
(Shattil et al., 1998; Parise, 1999).
Inside-out and outside-in signaling of integrins have been
suggested to involve the interaction between the cytoplasmic
domains of integrins and intracellular signaling molecules.
Interactions between the membrane-proximal regions of the
 
integrin 
 
 
 
IIb
 
 and 
 
 
 
3
 
 cytoplasmic domains are important in
maintaining a resting conformation of the integrin, and inside-
out signaling is associated with disruption of this interaction
(Hughes et al., 1996; Vinogradova et al., 2002). The cyto-
plasmic domain of 
 
 
 
IIb
 
 
 
3
 
 interacts with several intracellular
proteins, including cytoskeletal proteins such as talin
(Calderwood et al., 1999; Knezevic et al., 1996) and myosin
(Phillips et al., 2001), calcium-binding protein CIB (Naik et al.,
1997), phosphotyrosine-binding proteins SHC and GRB2
(Law et al., 1996), protein kinases such as integrin-linked
protein kinase (Hannigan et al., 1996), and 
 
 
 
3 endonexin
(Shattil et al., 1995). Binding of talin (Calderwood et al.,
1999, 2002) and 
 
 
 
3
 
 endonexin (Kashiwagi et al., 1997) to
 
 
 
3
 
 has been implicated in promoting integrin activation.
Binding of phosphotyrosine-binding proteins and focal
adhesion kinase has been suggested to play roles in outside-
in signaling (Law et al., 1996). Also, the 
 
 
 
3
 
 cytoplasmic domain
can be chemically modified during platelet activation. For
example, T
 
753
 
 (Lerea et al., 1999), Y
 
747
 
, and Y
 
759
 
 (Law et al.,
1996) are phosphorylated by protein kinases, and the
COOH-terminal region of 
 
 
 
3
 
 is cleaved by calpain at the
COOH-terminal side of Y
 
741
 
, T
 
747
 
, F
 
754
 
, and Y
 
759
 
 (Du et al.,
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*Abbreviation used in this paper: vWf, von Willebrand factor.
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1995). Phosphorylation at both Y
 
747
 
 and Y
 
759
 
 is critical to
outside-in signaling of the integrin (Law et al., 1999). The
roles of calpain cleavage of the 
 
 
 
3
 
 cytoplasmic domain in bi-
directional signaling of the integrin, however, are not clear.
The requirement for specific sequences in the 
 
 
 
3
 
 cyto-
plasmic domain in outside-in integrin signaling has been
indicated by mutagenesis studies in transfected CHO cell
models (Chen et al., 1994; Hughes et al., 1995; Ylanne et
al., 1995; Patil et al., 1999) and transgenic mouse models
(Law et al., 1999). Deletions or mutations that disrupted
the two NXXY motifs in the cytoplasmic domain of the
integrin abolished outside-in signal-dependent integrin
functions such as stable cell adhesion and cell spreading
(Ylanne et al., 1993, 1995; Chen et al., 1994; Patil et al.,
1999). In a transgenic mouse model, mutations replacing
both Y
 
747
 
 and Y
 
759
 
 in the NXXY motifs with phenylalanine
to disrupt tyrosine phosphorylation inhibited outside-in
signaling but had no significant effect on inside-out sig-
naling (Law et al., 1999). The requirement for the cyto-
plasmic domain of 
 
 
 
3
 
 in inside-out signaling has been
indicated by defective integrin activation in variant Glanz-
mann’s thrombasthenia patients whose 
 
 
 
3
 
 cytoplasmic do-
main either has a point mutation replacing S
 
752
 
 with pro-
line (Chen et al., 1992, 1994) or has a truncation mutation
at R
 
724
 
 (Wang et al., 1997). However, mapping of func-
tional sites important to inside-out signaling has been
hampered by the lack of a suitable inside-out signaling
model in cultured cells deficient in endogenous wild-type
 
 
 
3
 
, as recombinant integrin 
 
 
 
IIb
 
 
 
3
 
 expressed in CHO cells
is not activated by platelet agonists such as thrombin and
ADP (O’Toole et al., 1990). Although constitutively ac-
tive integrin mutants have been useful in characterizing
the affinity regulation by integrin cytoplasmic domains
(O’Toole et al., 1991, 1994; Hughes et al., 1995), these
mutants obviously bypass the normal on–off switch mech-
anism of inside-out signaling. We and others have recently
shown that integrin can be activated in a reconstituted
CHO cell model via the GPIb-IX pathway (Gu et al.,
1999; Zaffran et al., 2000; Li et al., 2001). In this model,
and as shown here, binding of vWF to GPIb-IX induces
inside-out signaling and results in activation of the fibrino-
gen-binding function of 
 
 
 
IIb
 
 
 
3
 
, which replicates the GPIb-
IX–induced inside-out signaling mechanism in platelets.
To understand the structural requirement of the 
 
 
 
3
 
 cyto-
plasmic domain in integrin inside-out signaling and the
role of calpain cleavage in regulating integrin signaling, we
have expressed different truncation mutants of 
 
 
 
3
 
 in this
reconstituted integrin activation model. We show that re-
moval of the NITY sequence abolished inside-out signal-
ing, whereas truncation of RGT sequence COOH terminal
to the NITY motif reduced outside-in signaling without
affecting inside-out signaling. Furthermore, a point muta-
tion changing Y
 
759
 
 to alanine abolished inside-out signal-
 
Figure 1.
 
Truncation mutants of 
 
 
 
IIb
 
 
 
3
 
 coexpressed with GPIb-IX 
in CHO cells.
 
 (A) Schematics showing truncation mutants of 
 
 
 
3
 
 that 
mimic calpain cleavage at four previously identified sites. A Y759A 
point mutation is also depicted. (B) The mutants described in A 
were cotransfected with 
 
 
 
IIb
 
 in a CHO cell line already expressing 
GPIb-IX, and stable cell lines were established. Expression of correct 
truncation mutants in each of the cell lines was verified by immuno-
blotting cell lysates with antibodies specifically recognizing calpain-
cleaved forms of 
 
 
 
3
 
 (Ab 741, Ab 747, Ab 754, and Ab 759) and with 
an antibody recognizing the COOH terminus of 
 
 
 
3
 
 (Ab 762). A 
cell line expressing wild-type 
 
 
 
IIb
 
 
 
3
 
 and GPIb-IX (123) was also 
immunoblotted with these antibodies as a control. (C) Levels of 
surface expression of wild type or mutants of 
 
 
 
IIb
 
 
 
3
 
 were examined 
by flow cytometry with an antibody recognizing 
 
 
 
IIb
 
 
 
3
 
 complex 
(D57) (dotted lines), and levels of GPIb-IX expression were examined 
 
with an antibody against GPIb
 
 
 
, SZ2 (shaded lines). Nonspecific 
mouse IgG was used as a negative control (solid lines). Please note 
that levels of expression of each of these mutants were comparable 
with 123 cells. Expression of GPIb-IX and integrin was also 
comparable with a cell line expressing GPIb-IX alone (1b9) and a 
cell line expressing 
 
 
 
IIb
 
 
 
3
 
 alone (2b3a), respectively.T
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Effects of 
 
 
 
3
 
 mutations on integrin activation 
(inside-out signaling)
 
To understand the roles of the COOH-terminal region of
 
 
 
3
 
 in inside-out signaling of 
 
 
 
IIb
 
 
 
3
 
, we examined vWF-
induced fibrinogen binding to cell lines expressing GPIb-IX
and truncation mutants of 
 
 
 
IIb
 
 
 
3
 
 (1b9/741, 1b9/747, 1b9/
754, and 1b9/759). Fig. 3 shows that truncation of the 
 
 
 
3
 
cytoplasmic domain at the site COOH terminal to Y
 
759
 
 did
not affect vWF-induced activation of fibrinogen binding to
integrin 
 
 
 
IIb
 
 
 
3
 
. In contrast, truncations at F
 
754
 
, Y
 
747
 
, or T
 
741
 
ing and reduced outside-in signaling. Thus, the NITY se-
quence is essential for both inside-out and outside-in
signaling of 
 
 
 
IIb
 
 
 
3
 
, and the RGT sequence is important for
outside-in signaling. Furthermore, localized calpain cleav-
age of 
 
 
 
3
 
 during platelet activation mainly occurs at a site
COOH terminal to Y
 
759
 
, suggesting that calpain cleavage
may selectively regulate outside-in signaling.
 
Results
 
CHO cell lines coexpressing mutants of the human 
integrin  IIb 3 and GPIb-IX
To study the roles of the COOH-terminal region of  3 in
integrin signaling, we have generated four truncation mu-
tants of the  3 subunit with truncations at sites COOH ter-
minal to T
741, Y
747, F
754, and Y
759. Truncations at these sites
also coincide with previously identified calpain cleavage sites
in   3 (Du et al., 1995; Fig. 1 A). These mutants were
cotransfected with the integrin  IIb subunit into a CHO cell
line that expresses recombinant human GPIb-IX complex
(1b9). Complex formation between these  3 mutants and
 IIb was verified by flow cytometry using an  IIb 3 com-
plex–specific monoclonal antibody, D57. Stable cell lines
expressing both GPIb-IX and integrin mutants (1b9/741,
1b9/747, 1b9/754, and 1b9/759) were obtained by cell
sorting with antibodies specific for integrin  IIb 3 and
GPIb-IX. Expression of correct mutants at each of the four
sites was verified by immunoblotting with antibodies that
specifically recognize each of these sites only when the site is
truncated (Du et al., 1995; Fig. 1 B). In addition, a cell line
coexpressing GPIb-IX and a mutant  IIb 3 bearing alanine
substitution of Y
759 in  3 was also established (1b9/Y759A).
Expression levels of GPIb-IX and integrin  IIb 3 on the
above mutant cell lines were comparable with a cell line ex-
pressing GPIb-IX and wild-type integrin  IIb 3 (123 cells)
at the time of experiments (Fig. 1 C).
Reconstituted CHO cell model of integrin 
 IIb 3 activation
We recently reported the reconstitution of GPIb-IX–medi-
ated integrin activation in CHO cells expressing recombi-
nant human GPIb-IX and integrin  IIb 3 (123 cells) (Gu et
al., 1999). In this reconstituted integrin activation model,
vWF binding to GPIb-IX in the presence of ristocetin acti-
vates fibrinogen binding to the 123 cells in an RGDS-
dependent manner, thus allowing the study of integrin in-
side-out signaling using a specific recombinant DNA ap-
proach. Although  3-transfected CHO cells also express an
 v 3 integrin composed of endogenous  v and recombinant
 3, Fig. 2 shows that vWF-induced fibrinogen binding to 123
cells is specifically inhibited by a monoclonal antibody that
recognizes human  IIb 3, but not by a blocking monoclonal
antibody that recognizes  v 3. Also, a cell line expressing
GPIb-IX and  3 without  IIb failed to show RGDS-depen-
dent fibrinogen binding under identical conditions (unpub-
lished data). These results indicate that vWF-induced fibrin-
ogen binding is mediated by  IIb 3 but not  v 3. Thus,
vWF-induced fibrinogen binding to 123 cells specifically re-
flects the activation of the platelet integrin  IIb 3.
Figure 2. vWF-induced activation of fibrinogen binding to cell 
lines coexpressing GPIb-IX and  IIb 3 reflects specific activation of 
integrin  IIb 3. (A) CHO cells (CHO), CHO cells coexpressing GPIb-IX 
and integrin  IIb 3 (123), and CHO cells coexpressing GPIb-IX and 
 3 in the absence of  IIb (1b9/ 3) were incubated with control mouse 
IgG,  IIb 3-specific antibodies, 2G12 and D57, and an antibody 
recognizing integrin  v 3, anti-VNR1. The reactivity of these 
antibodies was detected by flow cytometry. (B) 123 cells were 
preincubated with 100  g/ml of control mouse IgG, 2G12, or anti-
VNR1 (previously shown to inhibit ligand-binding functions of  IIb 3 
or  v 3, respectively) for 10 min at 22 C, and then Oregon green–
labeled fibrinogen (30  g/ml) was added and activated with vWF in 
the presence of ristocetin. Nonspecific binding was estimated by 
adding the integrin inhibitor RGDS. Quantitative results from three 
experiments (means   SD) are expressed as fibrinogen binding 
index (total bound fibrinogen/nonspecifically bound fibrinogen in 
the presence of RGDS). Statistical differences between samples 
were analyzed using the RRISM software and the Repeated Measures 
ANOVA method.T
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abolished vWF-induced integrin activation. Thus, it appears
that the RGT sequence at the COOH terminus of the  3 cy-
toplasmic domain is not required for integrin activation,
whereas the sequence between F
754 and Y
759, which contains
an NXXY motif, is required for integrin activation. To fur-
ther determine if the NXXY motif is important in integrin
activation, we examined vWF-induced fibrinogen binding
to CHO cells coexpressing GPIb-IX and the Y759A mutant
of integrin  IIb 3. Indeed, vWF-induced fibrinogen binding
was abolished in the Y759A mutant, indicating that the
NXXY motif, particularly Y
759, is required for vWF-induced
activation of  IIb 3.
Fibrinogen-binding function of the 
integrin  IIb 3 mutants
A possible alternative interpretation to the above results is
that the activation-defective mutants of  IIb 3 (754, 747,
and 741) may have a loss of function in the extracellular
ligand-binding site. To exclude this possibility, we examined
the fibrinogen-binding function of these mutants. It has
been demonstrated previously (Du et al., 1991) that binding
of the ligand mimetic peptide, RGDS, to the extracellular
ligand-binding domain of  IIb 3 transforms the integrin into
Figure 3. vWF-induced fibrinogen binding to wild type or various 
mutants of  IIb 3. (A) Cells (123, 1b9/741, 1b9/747, 1b9/754, 1b9/759, 
and 1b9/Y759A) suspended in modified Tyrode’s buffer were 
incubated at 22 C for 30 min with Oregon green–labeled fibrinogen 
(30  g/ml) and 1 mg/ml of ristocetin with (right) or without (left) 
adding 25  g/ml of vWF, and then were analyzed for fluorescence 
intensity by flow cytometry (solid lines). Nonspecific binding of 
fibrinogen was estimated by adding 1 mM RGDS (shaded lines). 
(B) Quantitative results from three experiments (means   SD) are 
expressed as fibrinogen binding index (total bound fluorescence 
intensity/nonspecifically bound fluorescence intensity).
Figure 4. Fibrinogen binding to mutants of  IIb 3 pretreated with 
RGDS peptide. Cells coexpressing GPIb-IX and wild-type  IIb 3 (123) 
or integrin mutants were preincubated with or without 1 mM of 
RGDS peptide for 10 min and then fixed with paraformaldehyde 
(1% in PBS) for 30 min at 22 C. As a negative control, cells expressing 
GPIb-IX alone (1b9) were identically treated. The cells were washed, 
resuspended in modified Tyrode’s buffer at a concentration of 
5   10
5/ml, and then incubated with Oregon green–labeled fibrinogen 
for 30 min. Fibrinogen binding was detected by flow cytometry. 
Nonspecific binding was estimated by adding RGDS peptide to the 
assay. Specific fibrinogen binding was determined by subtracting the 
geometric means of fluorescence intensity of the nonspecific binding 
from that of total binding. Shown in the figure are the data (mean   SD) 
from three experiments.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
Roles for NITY sequence in  3 integrin signaling | Xi et al. 333
an active conformation. After fixation and removal of
RGDS, the activated integrin is able to bind fibrinogen.
Thus, we examined RGDS-induced fibrinogen binding to
cells expressing mutants of  IIb 3 (Fig. 4). All of the above
mutant cell lines bound fibrinogen in a manner similar to
wild-type integrin  IIb 3 (123 cells). In contrast, 1b9 cells,
in which no integrin  IIb 3 was expressed, did not bind fi-
brinogen after RGDS treatment. These data suggest that the
activation-defective mutants used in this study retained fi-
brinogen-binding function. Therefore, the inability of these
mutants to bind fibrinogen after vWF stimulation results
from a deficiency in inside-out signaling.
Effect of mutations on cell adhesion and spreading 
under static conditions
An important function for  IIb 3 is to mediate stable plate-
let adhesion and spreading on immobilized integrin ligands
such as vWF and fibrinogen. Integrin-dependent stable cell
adhesion and spreading on vWF are significantly enhanced
by inside-out signaling induced by GPIb-IX–vWF interac-
tion (Savage et al., 1992) and also require integrin outside-
in signaling. Integrin  IIb 3–mediated stable cell adhesion
and spreading to immobilized fibrinogen, however, do not
require inside-out signaling (Coller, 1980; Savage et al.,
1992) but are dependent upon ligand-induced integrin ac-
tivation and outside-in signaling (Du et al., 1991; Phillips
et al., 1991; Ginsberg et al., 1995; Shattil et al., 1998).
Thus, to determine the roles of the COOH-terminal re-
gion of  3 in outside-in and inside-out signaling, we exam-
ined stable adhesion and spreading of the mutant cell lines
to fibrinogen and vWF. As previously reported (Gu et al.,
1999), CHO cells (without transfected GPIb-IX and inte-
grin  IIb 3) poorly adhere to vWF or fibrinogen. CHO
cells expressing GPIb-IX alone also poorly adhere to both
vWF and fibrinogen (Fig. 5). Even in the presence of
botrocetin, which enhances the GPIb-IX binding affinity
of vWF and allows GPIb-IX–dependent stable cell adhe-
sion to vWF, these cells poorly spread on vWF (unpub-
lished data), indicating that  3 integrin is required for cell
spreading on vWF (Gu et al., 1999). As expected, CHO
Figure 5. Effects of mutations on integrin-dependent stable cell 
adhesion and spreading on vWF or fibrinogen (Fg) under static 
conditions. The indicated cell lines in modified Tyrode’s buffer (10
6/ml) 
were allowed to incubate in fibrinogen- or vWF-coated microtiter 
wells at 37 C for 1 h. The wells were washed three times, and the cells 
remaining adherent were quantitated using an acid phosphatase assay, 
as described under the Materials and methods (A), and photographed 
to document cell spreading (B). The means and standard deviations of 
triplicate samples are shown in A.T
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cells expressing integrin  IIb 3 (2b3a) showed high levels of
adhesion and spreading on fibrinogen but poorly adhered
to vWF within the first hour of incubation (Fig. 5). How-
ever, with prolonged incubation, adhesion of 2b3a cells to
vWF was slowly increased (unpublished data), suggesting a
low affinity interaction between  3 integrins and vWF. Co-
expression of GPIb-IX with  IIb 3 (123 cells) significantly
enhanced and accelerated integrin-dependent cell adhesion
and spreading on vWF, indicating that GPIb-IX activates
integrin, leading to integrin-dependent cell spreading and
stable adhesion. Cleavage of  3 at or NH2 terminal to
F
754 inhibited integrin-dependent stable cell adhesion and
spreading on vWF and fibrinogen (Fig. 5), which is consis-
tent with previous findings that this region of the integrin
cytoplasmic domain is important for adhesion and spread-
ing (Ylanne et al., 1993, 1995). Interestingly, truncation of
 3 at Y
759 also showed a reduced stable adhesion to both
vWF and fibrinogen, and most 1b9/759 cells that adhered
to fibrinogen or vWF spread poorly (Fig. 5). Reduced sta-
ble adhesion in 1b9/759 cells was not caused by a defect in
inside-out signaling, as  IIb 3-dependent cell adhesion to
fibrinogen under these conditions does not require inside-
out signaling, and 1b9/759 cells showed normal inside-out
signaling, as indicated by soluble fibrinogen binding (Fig.
3). Reduced stable adhesion of 1b9/759 cells is likely re-
sultant from a decreased resistance to the washing proce-
dure in the adhesion assay, as gentler washing can signifi-
cantly increase 1b9/759 cell adhesion (unpublished data;
Fig. 6). Thus, reduced cell adhesion and spreading in 1b9/
759 cells suggest that integrin outside-in signaling in this
truncation mutant is impaired.
Effects of integrin  3 mutations on cell adhesion 
under flow
A major physiological role of GPIb-IX–induced integrin ac-
tivation is to mediate stable platelet adhesion to immobilized
vWF. Under flow conditions, initial transient platelet adhe-
sion and rolling on vWF are mediated by GPIb-IX. Interac-
tion of vWF with GPIb-IX induces integrin activation and
integrin-dependent stable platelet adhesion. Thus, if the
mutations of  IIb 3 abolished integrin inside-out signaling,
these mutants should also show defective stable adhesion to
vWF under flow conditions. To determine this, the above-
described cell lines were perfused through a capillary tube
precoated with human vWF. At shear rates below 50 s
 1, the
cells expressing integrin mutants 1b9/754, 1b9/747, and
1b9/741 (all defective in inside-out signaling) were defective
in stable cell adhesion to vWF compared with 123 cells ex-
pressing wild-type  IIb 3 (Fig. 6). The amount of adherent
1b9/759 mutant cells on vWF, in contrast, was not reduced.
Thus, the results in cell adhesion to vWF under this low
shear rate condition mirrored integrin activation indicated
by fibrinogen binding. However, when the flow shear rate
was further increased to 100 s
 1 or above, not only the inte-
grin activation–deficient mutants, but also 1b9/759 cells
showed significantly reduced adhesion to vWF, suggesting
that the ability of 1b9/759 cells to resist shear force is im-
paired. This is consistent with the above results that 1b9/
759 cells showed decreased adhesion in the static adhesion
assay, which involves multiple washes with considerable
shear force. As the vWF-induced ligand-binding function of
the  759 mutant is normal, we conclude that the impaired
outside-in signaling function of this mutant reduced the
Figure 6. Effects of mutations on 
GPIb-IX–induced, integrin-dependent 
cell adhesion to vWF under flow 
conditions. Cells coexpressing GPIb-IX 
with wild type and different mutants of 
 IIb 3 as well as control cells expressing 
GPIb-IX alone or  IIb 3 alone (5   10
6/ml 
in modified Tyrode’s buffer containing 
5% BSA) were perfused though the 
capillary tubes precoated with vWF at 
indicated shear rates for 2 min, followed 
by a further 10-min perfusion with 
Tyrode’s buffer at the same shear rate to 
wash out transient adherent cells. Cell 
interaction with immobilized vWF under 
flow conditions was observed under an 
inverted microscope and recorded on 
videotapes. The number of stable adherent 
cells on vWF was counted on images 
obtained at 10 randomly selected 
positions in each vWF-coated capillary 
tube. The difference between the control 
123 cells with each of the other cell 
lines was analyzed by t test and shown 
to be highly significant (P   0.01), unless 
otherwise indicated.T
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ability of 1b9/759 cells to resist shear stress. Together, these
results indicate that the RGT sequence at the COOH termi-
nus of  3 is important for outside-in signaling of  IIb 3, but
the NITY sequence is important for both inside-out and
outside-in signaling.
Differential cleavage at different sites of the  3 
cytoplasmic domain by calpain in platelets
We have shown previously that calpain may cleave the cyto-
plasmic domain of  3 at sites COOH terminal to T
741, Y
747,
F
754, and Y
759, which generates  3 fragments identical to the
above-described truncation mutants of  3 (741, 747, 754,
and 759). As we showed above that truncations at these dif-
ferent sites result in different functional effects on integrin
signaling, our results also indicate that cleavage of the  3 cy-
toplasmic domain at these different sites has the potential to
differentially regulate outside-in and inside-out signaling of
integrin  IIb 3. To determine if calpain differentially cleaves
the  3 integrin at different sites during platelet activation,
washed platelets were treated with or without thrombin (0.1
U/ml) and then immunoblotted for calpain cleavage by the
cleavage-specific antibodies (Du et al., 1995). We found that
anti-759 antibody, which only recognizes  3 molecules with
cleavage at Y
759, reacted with  0.8% of the integrin  IIb 3
molecules in washed “resting” platelets (Fig. 7). This reaction
was unlikely to result from cross-reaction of this antibody
with the intact  3 subunit, because we showed that the anti-
body did not react with the intact  3 subunit but reacted
with the  759 mutant expressed in CHO cells (Fig. 2). Thus
a very small percentage of the  3 molecules in resting platelets
has been cleaved at the Y
759 site. Stimulation of platelets with
thrombin caused a time-dependent and significant increase
in the cleavage at Y
759. In contrast to the 759 site, calpain
cleavage at T
754 or Y
747 (Fig. 7) occurred to a much lesser de-
gree and only after a much longer exposure to thrombin.
Calpain cleavage at the 741 site was not detectable in throm-
bin-stimulated platelets (unpublished data) but was detected
in platelets treated with calcium ionophore A23187 (Du et
al., 1995). Thus, in thrombin-activated platelets, calpain
preferentially cleaves  3 at Y
759. As we showed above that
cleavage at Y
759 selectively reduced integrin outside-in signal-
ing without affecting inside-out signaling, this result indi-
cates that calpain cleavage has the potential to selectively reg-
ulate outside-in signaling during platelet activation.
Distribution of calpain-cleaved  3 
in spreading platelets
Calpain only cleaves a percentage of  3 molecules in platelets
stimulated with thrombin, suggesting that cleavage of  3 is
likely to have only a localized effect on integrin function. It is
known that during cell spreading on integrin ligands, inte-
grin forms a localized signaling complex with cytoskeletal
and signaling molecules that is dynamically regulated and in-
volves calpain activity (Bialkowska et al., 2000). To deter-
mine if selective integrin cleavage occurred at specific regions
during platelet spreading on integrin ligands, platelets were
allowed to spread on fibrinogen for 60 min and then dou-
ble stained with calpain cleavage–specific antibodies and a
monoclonal antibody against an extracellular epitope of  3
that is not affected by calpain cleavage. Consistent with the
above results in thrombin-stimulated platelets, calpain cleav-
age occurred mainly at Y
759 (Fig. 8), but cleavages at F
754
(Fig. 8) or the more NH2-terminal sites (unpublished data)
were significantly weaker. Whereas the  3 molecules were
distributed throughout the spreading platelets with particu-
larly strong staining at the edges, calpain-cleaved  3 was not
seen at the edges (or in the pseudopods) but was concen-
trated in the central region of the spreading platelets as clus-
ters. As integrin engagement with immobilized ligands starts
from the central region where discoid platelets initially ad-
here, our data suggest that cleavage of  3 by calpain occurred
only to the population of the integrin that is no longer at the
leading edge of spreading platelets. This selective cleavage of
the centrally located integrin population (mainly at Y
759) may
Figure 7. Progressive cleavage at different sites of the  3 cytoplasmic 
domain by calpain. Washed human platelets (10
9/ml) were directly 
solubilized in SDS-PAGE sample buffer containing EDTA and E64 
(Control), or treated with thrombin (0.1 U/ml) for increasing lengths 
of time at 37 C before being solubilized. Platelet lysates were then 
immunoblotted with Ab759, Ab754, Ab747, and Ab741 to detect 
calpain cleavages at Y
759, F
754, T
747, and Y
741 sites, with Ab762 
to detect uncleaved  3 and Mab 15 to detect total  3 levels. 
Quantification of antibody reactions was performed by scanning 
the immunoblots and analyzing using NIH Image as described 
under the Materials and methods. Percentages of the molecules 
cleaved (or uncleaved) at a particular site are shown in B.T
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serve to down-regulate local integrin outside-in signaling in
these areas without affecting the activation state of the inte-
grin. It is possible that selective cleavage of integrin at Y
759
may serve to facilitate the reorganization of the integrin–cyto-
skeleton signaling complex during platelet spreading.
Discussion
By using a reconstituted integrin activation and adhesion
model in transfected CHO cells and a panel of truncation
mutants of the integrin  IIb 3, we show that the N
756ITY
759
motif of the  3 cytoplasmic domain plays a critical role in
inside-out signaling of the integrin  IIb 3, and the COOH-
terminal R
760GT
762 sequence of  3 is important in outside-
in signaling–dependent events. Furthermore, we show that
calpain preferentially cleaves a population of  3 at Y
759 in
thrombin-activated platelets as well as in platelets spreading
on fibrinogen, suggesting that calpain may selectively regu-
late outside-in signaling of the integrin.
We conclude that the NITY sequence of the  3 cytoplas-
mic domain is critical to the inside-out signaling function of
 IIb 3. This conclusion is supported by the finding that de-
letion of the RGT sequence COOH terminal to the NITY
motif did not affect vWF-induced integrin activation, but
deletion of the TNITY sequence completely abolished inte-
grin activation. The importance of the NITY sequence in in-
side-out signaling is further supported by the data that the
Y759A point mutation inhibited vWF-induced integrin
activation. Also, we show that inhibition of vWF-induced fi-
brinogen binding is not caused by loss of the fibrinogen-
binding function per se, as RGDS-induced fibrinogen bind-
ing to either 1b9/754 or 1b9/Y759A mutant cells was not
different from the wild-type integrin. Furthermore, our data
indicate that the NITY sequence and the COOH-terminal
RGT sequence are both important for outside-in signaling
of  IIb 3 and integrin-dependent stable cell adhesion and
spreading. This is consistent with previous work showing
that this region of the  3 cytoplasmic domain is important
in cell spreading and focal adhesion formation (Ylanne et al.,
1993, 1995). Thus, the NITY motif is important for both
inside-out and outside-in signaling of the integrin  IIb 3.
The NITY motif contains a tyrosine residue that becomes
phosphorylated during platelet aggregation (Law et al.,
1996). The phosphorylated NXXY motifs have been
shown to interact with several intracellular molecules, includ-
ing myosin and phosphotyrosine-binding proteins such as
GRB2 and SHC (Cowan et al., 2000), which are implicated
in integrin outside-in signaling. It has been shown that mu-
tation of both tyrosine residues to phenolalanines selectively
abolished outside-in signaling in transgenic mouse platelets
(Law et al., 1999), suggesting that phosphorylation of one or
both of these tyrosine residues is important for outside-in
signaling but not for integrin activation (inside-out signal-
ing). Thus, although we conclude that the NITY sequence is
essential for inside-out signaling, phosphorylation at Y
759 is
unlikely to be involved in this process. In this regard, a func-
tional difference between Y759F and Y759A mutations has
been shown previously (Schaffner-Reckinger et al., 1998).
Y759A, but not Y759F, inhibited integrin-dependent cell
adhesion. Furthermore, tyrosine phosphorylation occurs
only after platelet aggregation, suggesting that inside-out sig-
naling does not involve tyrosine phosphorylation in the
NXXY motifs (Law et al., 1996, 1999).
It is interesting to note that although the NITY sequence is
important for both inside-out and outside-in signaling, there
is a significant difference in the structural requirement be-
tween inside-out signaling (integrin activation) and outside-
in signaling. Cleavage of the COOH-terminal three residues
did not affect inside-out signaling but significantly inhibited
outside-in signaling–dependent integrin function, such as
cell spreading and stable cell adhesion. On the other hand,
disruption of the NITY sequence by Y759A mutation abol-
Figure 8. Localization of calpain-cleaved  3 in spreading platelets. 
Platelets in Tyrode’s buffer (1   10
8/ml) were incubated in the 
chamber slides precoated with 20  g/ml fibrinogen for 2 h at 37 C. 
After three washes, the adherent platelets were fixed with 4% 
paraformaldehyde and permeabilized. The slides were incubated 
subsequently with Mab15, specific for integrin  3 extracellular domain 
(green), and with one of the cleavage site–specific antibodies (Ab759 
and Ab754) or an antibody against the COOH terminus of  3 
(Ab762) (red), and then with Alexa Fluor 488–conjugated anti–
mouse IgG antibody and Alexa Fluor 546–conjugated anti–rabbit 
IgG antibodies. The slides were scanned under a confocal microscope 
(63  lens). Images of the green and red fluorescence overlay are 
shown in the left column. Green fluorescence (Mab15) from the 
same images is shown in the middle column. Red fluorescence 
(cleavage site–specific antibodies) from the same images is shown 
in the right column.T
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ished vWF-induced integrin activation (as indicated by solu-
ble fibrinogen binding) and partially (although significantly)
inhibited cell spreading and stable cell adhesion on fibrino-
gen. In addition, previous work suggests that outside-in sig-
naling, but not inside-out signaling, requires phosphoryla-
tion at tyrosine residues (Law et al., 1999). The difference in
the structural requirements between inside-out and outside-
in signals suggests that inside-out and outside-in signals may
be mediated by different molecules (or mechanisms) that in-
teract with the COOH-terminal region of  3 during platelet
adhesion and aggregation. This also suggests that inside-out
and outside-in signals can be differentially regulated.
The family of the calcium-dependent intracellular pro-
teases, calpain, plays important roles in cytoskeletal reorga-
nization, cell migration, platelet aggregation, and clot retrac-
tion (Fox et al., 1983; Huttenlocher et al., 1997; Croce et
al., 1999; Bialkowska et al., 2000; Azam et al., 2001). We
have shown previously that the  3 cytoplasmic domain is
cleaved by either calpain I or calpain II at sites flanking two
NXXY motifs in human platelets (Du et al., 1995; Pfaff et
al., 1999). Calpain cleavage of the  3 cytoplasmic domain
also occurs during endothelial cell apoptosis (Meredith et al.,
1998). The physiological roles of calpain cleavage of  3 have
been unclear. Calpain I knockout in mouse inhibited plate-
let aggregation but did not affect  3 cleavage. This suggests
that cleavage of the  3 subunit is not involved in promoting
platelet aggregation (Azam et al., 2001). Here we show that
one of the functional consequences of calpain cleavage of  3
is to negatively regulate the signaling functions of integrin
 IIb 3. Furthermore, we show that cleavage by calpain at dif-
ferent sites of  3 may result in different regulatory effects.
Cleavage at Y
759 has no significant effect on inside-out sig-
naling but significantly reduces the integrin functions associ-
ated with outside-in signaling. In contrast, cleavage at F
754
or further NH2-terminal sites abolishes both inside-out and
outside-in signaling. Nevertheless, cleavage at these sites oc-
curs much later during platelet activation (Figs. 7 and 8),
suggesting that such cleavages are not important for the early
phase of integrin activation. On the other hand, we found
that calpain cleavage of integrin  3 subunit in intact platelets
mainly occurs at the most COOH-terminal Y
759 site during
platelet activation and adhesion (Figs. 7 and 8). Further-
more, cleavage of  3 does not appear to occur to the integrin
molecules at the leading edge of spreading platelets but oc-
curs to more centrally localized integrin molecules. Thus, it
is likely that cleavage at Y
759 serves to selectively down-regu-
late outside-in signaling in the integrin–cytoskeletal signal-
ing complexes that have been formed during the earlier stage
of platelet spreading, thereby facilitating the dynamic reor-
ganization of the integrin–cytoskeleton signaling complex
during platelet spreading.
Materials and methods
Reagents and cell lines
Human vWF was purified as described previously (Booth et al., 1984). Hu-
man   -thrombin was purchased from Enzyme Research Laboratories.
RGDS peptide was from Bachem, and ristocetin was from Sigma-Aldrich.
Monoclonal antibodies against integrin  v 3 (anti-VNR1) (O’Toole et al.,
1990), against integrin  3 (Mab15) (Frelinger et al., 1990), and against the
integrin  IIb 3 complex (D57 and 2G12) (Frojmovic et al., 1991) were pro-
vided by M. Ginsberg (The Scripps Research Institute, La Jolla, CA) and V.
Woods (University of California, San Diego, CA). Monoclonal antibodies
against GPIb (SZ2) (Ruan et al., 1987) were a gift from C. Ruan (Jiangsu In-
stitute of Hematology, Suzhou, China). Calpain cleavage site–specific anti-
bodies were generated by immunizing rabbits with pentapeptides (AK-
WDT for Ab741, NNPLY for Ab747, ATSTF for Ab754, TNITY for Ab759,
and TYRGT for Ab762) as described previously (Du et al., 1995). Oregon
green 488–conjugated human fibrinogen, Alexa Fluor 488–conjugated
goat anti–mouse IgG, and Alexa Fluor 546–conjugated goat anti–rabbit
IgG were from Molecular Probes. Integrin  IIb and  3 cDNA clones in
pCDM8 vector were provided by M. Ginsberg, and a mutant  3 cDNA
clone bearing the Y
759A substitution was a gift from J. Ylänne (University of
Helsinki, Helsinki, Finland). Cell lines expressing GPIb-IX complex (1b9),
integrin  IIb 3 (2b3a), or both GPIb-IX and  IIb 3 (123) were described pre-
viously (Gu et al., 1999).
Construction of truncation mutants of  3 subunit
Truncation mutagenesis was performed using PCR to introduce stop codons
into integrin  3 cDNA at sites corresponding to the carboxy side of amino
acid residues 741, 747, 754, or 759, respectively. The forward primer has
the sequence of AGAGCTTAAGGACAC at an AflII site of  3 cDNA. The re-
verse primers contain an XhoI digestion site, a stop codon, and the 18-
nucleotide  3 sequences at the intended COOH terminus of each mutant.
The PCR products were digested with restriction enzymes AspI and XhoI
and ligated into a  3 cDNA construct in a modified cDM8 vector contain-
ing only the 3 -end XhoI site that was digested with the same restriction en-
zymes. All mutant constructs were verified by DNA sequencing.
Expression of mutant  3 cDNA constructs in CHO cells
CHO cells expressing GPIb-IX (1b9) were maintained in DEAE medium
supplemented with 10% FBS, glutamine, and nonessential amino acid.
Transfection was performed using LipofectAMINE 2000 (Life Technolo-
gies). Each mutant  3 cDNA was cotransfected together with wild-type  IIb
and pcDNA3.1/Hyg plasmid at a ratio of 5:5:1. Stable cell lines expressing
mutant  3 were selected in 0.2 mg/ml of hygromycin (Invitrogen). Expres-
sion of integrin  IIb 3 was monitored by flow cytometry using D57. Expres-
sion of GPIb-IX was detected using SZ2. Cells expressing both GPIb-IX and
integrin  IIb 3 were selected by cell sorting. All cell lines were sorted using
the expression levels of 123 cells as a gate until similar levels of expression
were achieved. To verify correct expression of calpain cleavage–mimick-
ing mutants, cells were also solubilized and electrophoresed on 7% poly-
acrylamide gels and then immunoblotted with various cleavage-specific
antibodies followed by detection using the ECL kit from Amersham.
Fibrinogen binding to transfected CHO cells activated by vWF
Activation of  IIb 3 induced by ristocetin and vWF was examined by flow
cytometric analysis of Oregon green 488–conjugated fibrinogen binding to
 IIb 3, as previously described (Gu et al., 1999; Li et al., 2001). In brief,
transfected CHO cells were resuspended to 5   10
5/ml in modified Ty-
rode’s solution (2.5 mM Hepes, 150 mM NaCl, 2.5 mM KCl, 12 mM
NaHCO3, 5.5 mM D-glucose, 1 mM CaCl2, 1 mM MgCl2, 0.1% BSA, pH
7.4), incubated with Oregon green 488–conjugated fibrinogen (30  g/ml)
and ristocetin (1 mg/ml) in the presence or absence of purified human vWF
(25  g/ml) at 22 C for 30 min, and analyzed by flow cytometry. Nonspe-
cific binding of fibrinogen was estimated by measuring fibrinogen binding
in the presence of an integrin inhibitor, RGDS (1 mM).
Fibrinogen binding induced by RGDS peptide
RGDS pretreatment–induced fibrinogen binding was assayed according to
a previously described method (Du et al., 1991). Cells in modified Ty-
rode’s solution were incubated with 1 mM RGDS peptide at 22 C for 10
min. Paraformaldehyde–PBS was then added (to a final concentration of
1%), and the mixture was incubated at 22 C for 1 h. After adding 250 mM
NH4Cl, the fixed cells were washed, resuspended in modified Tyrode’s so-
lution, and incubated with Oregon green 488–conjugated fibrinogen (30
 g/ml) for 30 min before flow cytometric analyses.
Cell adhesion under static conditions
Microtiter wells were coated with 10  g/ml human vWF or fibrinogen in 0.1 M
NaHCO3, pH 8.3, at 4 C overnight and then blocked with 5% BSA–PBS at
22 C for 2 h. Cell suspension (10
6/ml in modified Tyrode’s buffer with 1%
BSA) was added to ligand-coated microtiter wells and incubated for 60 min
at 37 C in a CO2 incubator. After three washes, cell spreading was exam-
ined under an inverted microscope (20  objective lens). In quantitative as-
says, 50  l of 0.3% p-nitrophenyl phosphate in 1% Triton X-100, 50 mMT
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sodium acetate, pH 5.0, was added to microtiter wells and incubated at
37 C for 1 h. The reaction was stopped by adding 50  l of 1 M NaOH. Re-
sults were determined by reading the OD at a 405-nm wavelength.
Cell adhesion under flow
Purified human vWF (100  g/ml with 0.1 mM NaHCO3, pH 8.3) was
added into a glass capillary tube (0.59 mm ID, 75 mm in length; Harvard
Apparatus Inc.) and then incubated overnight in a humid environment at
4 C (Englund et al., 2001). The capillary tubes were rinsed with PBS and
then blocked with 5% BSA in PBS. CHO cells expressing human platelet
receptors (5   10
6/ml in modified Tyrode’s buffer containing 5% BSA)
were perfused with a syringe pump (Harvard Apparatus Inc.) through the
capillary tube at various shear rates for 2 min followed by perfusion for 10
min with cell-free buffer at the same shear rates. Shear rate was calculated
as described by Slack and Turitto (1994). Cell interaction with immobi-
lized vWF was observed in real time under an inverted microscope and re-
corded on videotapes. The number of stable adherent cells on immobi-
lized vWF was counted on images obtained in 10 randomly selected fields
in the vWF-coated tubes. The statistical difference between 123 cells and
each one of the mutant cell lines was determined using the t test.
Calpain cleavage of integrin  3 subunit in human platelets
Preparation of washed human platelets has been described previously (Li
et al., 2003). Platelet aggregation was induced in a Chronolog lumi-aggre-
gometer by adding 0.1 U/ml thrombin with constant stirring at 1,000 rpm
for various lengths of time. The reaction was stopped by adding an equal
volume of 2  SDS-PAGE sample buffer containing 1 mM EDTA, 1 mM
PMSF, and 0.1 mM E64. Samples were then analyzed by SDS-PAGE on a
7% gel and immunoblotted with cleavage-specific antibodies (Du et al.,
1995). The densities of reactive bands were scanned and then quantitated
using NIH Image. Lysates prepared from 123, 1b9/747, 1b9/754, and 1b9/
579 CHO cell lines were used as internal calibration standards for each of
the cleavage-specific antibodies. The ratio of cleaved  3 molecules was
calculated as the ratio between the optical density of the reaction of an an-
tibody with platelet lysates and the reaction of the same antibody with the
corresponding standard CHO cell lysates multiplied by the ratio between
the  3 levels in the standard CHO cell lysates and the  3 level in platelet
lysates (as determined by immunoblotting with Mab15 directed against the
extracellular domain of  3). 
Immunofluorescence analysis of calpain-cleaved  3 
in spreading platelets
Platelets in modified Tyrode’s buffer (1   10
8/ml) were allowed to adhere
to the Lab-Tek chamber slides (Nunc) precoated with 20  g/ml of fibrino-
gen at 37 C for 2 h as previously described (Bodnar et al., 1999). The
chamber slides were rinsed three times. Adherent platelets were fixed with
1% paraformaldehyde and permeabilized with 0.1 M Tris, 10 mM EGTA,
0.15 M NaCl, 5 mM MgCl2, 1 mM PMSF, 0.1 mM E64, 0.1% Triton X-100,
1% BSA, pH 7.5. The samples were incubated first with Mab15 and one of
the cleavage-specific antibodies and then with Alexa Fluor 488–conju-
gated goat anti–mouse IgG and Alexa Fluor 546–conjugated goat anti–rab-
bit IgG. The slides were then scanned under a Carl Zeiss MicroImaging,
Inc. LSM510 confocal microscope (63  objective lens).
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